Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition-Reference-Cited by-同舟云学术

Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition

Published:2012-03 Issue:5 Volume:11 Page:1029-1039
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Cozzi Martina,Giorgi Francesca,Marcelli Eleonora,Pentimalli Francesca,Forte Iris Maria,Schenone Silvia,D’Urso Vittorio,De Falco Giulia,Botta Maurizio,Giordano Antonio,Indovina Paola

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.11.5.19519

Reference47 articles.

1. The molecular background of aggressive B cell lymphomas as a basis for targeted therapy;de Jong;J Pathol,2011

2. Leoncini L, Raphael M, Stein H, Harris NL, Jaffe ES, Kluin PM. Burkitt lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW eds. WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissue. Volume 2, 4th edition. Lyon, France. 2008; 262-264.

3. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen;Magrath;J Clin Oncol,1996

4. Burkitt’s lymphoma: clinicopathologic features and differential diagnosis;Ferry;Oncologist,2006

5. Clinical aspects and therapy of sporadic burkitt lymphoma;Pagano;Mediterr J Hematol Infect Dis,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review;Medicinal Chemistry;2023-10-25

2. Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme;Pharmaceutics;2023-01-30

3. The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression;Frontiers in Oncology;2022-06-27

4. Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies;DNA Repair;2021-11

5. New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors;Cancers;2021-10-22